[1]
Slatkin, MD, N.E., Rhiner, RN, MSN, NP, M.I., Gould, PhD, E.M., Ma, PhD, T. and Ahdieh, PhD, H. 2018. Long-term tolerability and effectiveness of oxymorphone extended release in patients with cancer. Journal of Opioid Management. 6, 3 (Jan. 2018), 181–191. DOI:https://doi.org/10.5055/jom.2010.0016.